Archive for May, 2008
As mentioned in my prior post, there was a first at BioFinance this year – a panel on Cleantech, and a number of Cleantech presenting companies.
The discussion began with the question: Is cleantech the future of life science? (maybe for investors looking for quicker and more reliable returns on investment?! take a look where the dollars are going! The Cleantech sector is now outperforming other sectors, it is the best sector in US stock market and was up 46% last year.
Deloitte is compiling the “Green 15″, from 150 candidates who have submitted profiles this year. Interestingly, some companies seem to be waivering between life sciences and cleantech – they just can’t decide where they are or where they should be. After all, if they call themselves a life science company, investors approach cautiously … but that’s just me being cynical.
Susan McLean, a Senior Manager of Business Development at the TSX, gave an interesting overview of the sector. The TSX had 94 cleantech issues in 2007, and it is growing. In fact, there was a tripling of activity from 2005 to 2007, progressing well in 2008; there were 2.5 billion shares traded in 2007. It is looking at pure-play companies and integrated companies. Some sub-sectors of listed companies include solar, wind, hydro, geothermal, fuel cell, waste to energy, and others. Now, for the best part – companies even at the $50 million value are getting analyst coverage – something unseen for many “small” companies on US exchanges.
Another panelist was a well-recognized member of Bay Street, Steven Winokur from Canaccord Adams. A few high-level points came out of his talk. He recognized Cleantech to be the best performing sector. There are a number of biotech applications in Cleantech that he mentioned:
- Agriculture: genetic crop technologies, organic fertilizers, water/waste remediation
- Nanotechnology for desalinization
- Biofuels – lignol, syntec biofuel
- Green Building – a noted possibility
Canaccord Adams puts out a newsletter with quality research reports each month, and they are a highly recommended read by Duncan Stewart, from Deloitte.
I have certainly been neglecting my blogging recently! I have been busy focusing on completing my masters degree, and delivering good results at my internship with GSK. Either way, sorry to dissappoint my readers who used to come by here much more often!
This week I will be attending BioFinance, a conference known to bring together early-stage life science and medical devices companies. In fact, I will be volunteering at the partnership desk, so I will get to work with a number of the companies during my time slot there.
This year will mark the 3rd BioFinance conference that I have attended – I must say that heading out to these types of events really helps to grasp the state of the financial markets and the state of entrepreneurial ventures in the Canadian marketplace, particularly in the biotechnology/pharmaceutical sector. It is also the first time that I have ever seen a focus on Cleantech; there is a luncheon with a Cleantech panel and then a number of Cleantech company presentations on the Thursday afternoon. I will try my best to report back on some interesting leads there.
The Luncheon with the Cleantech Panel will include:
Moderator: Duncan Stewart, Deloitte and National Post
Panel: (1) Dr. Jürgen Scheffran, Center for Advanced BioEnergy Research University of Illinois; (2) John Cook, Investeco Financial Corporation; (3) Steven Winokur, Canaccord Adams; (4) Alex Kilgour, Gowling Lafleur Henderson LLP; and (5) Susan McLean, TSX Group Inc.